Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 September 2008, doi:10.1136/bmj.a1596
Cite this as: BMJ 2008;337:a1596
Michael Papadakis, cardiac research registrar1,2, Greg Whyte, professor of sports sciences3, Sanjay Sharma, consultant cardiologist, and director of heart muscle diseases1,2
1 Kings College Hospital, London SE5 9RS, 2 University Hospital Lewisham, London, 3 CRY Sports Cardiology Centre, Olympic Medical Institute, Northwick Park Hospital, Middlesex
Correspondence to: S Sharma ssharma21@hotmail.com
| The first 150 words of the full text of this article appear below. |
The cardiovascular benefits of regular physical exercise are well established.1 However, a small proportion of young (
35 years) athletes with unsuspected heart disease are at increased risk of exercise related sudden cardiac death.2 The majority of such deaths are attributable to cardiac anomalies,2 3 4 most of which can be identified during life. A range of therapeutic strategies can be implemented to prevent fatalities, raising support for screening young athletes in medical and sporting communities.5 6 7 8 9 The efficacy, cost effectiveness, and impact of false positive tests of preparticipation screening strategies are, however, controversial. This article provides a factual overview of preparticipation screening, as more general practitioners are likely to be confronted with the questions relating to cardiovascular screening in athletes in countries where systematic screening programmes are currently not available.
|
Read all Rapid Responses